Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jürgen Alt"'
Autor:
Sofia Hornetz, Daniel C. Christoph, Helge Bischoff, Sebastian Michels, M Kimmich, Jürgen Alt, Monica Schäfer, Werner Spengler, Frank Griesinger, Martin Sebastian, Annette Müller, Jan Stratmann, Eckart Laack, S. Sackmann
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 144:2457-2463
Osimertinib, a third-generation irreversible mutant-selective inhibitor of EGFR kinase activity was clinically evaluated in the AURA trials, where it showed high clinical efficacy and a favorable toxicity profile in patients with acquired exon 20-EGF